Splitting Up the Combination Vaccines
President Trump announced on Sept. 18, 2026 that his administration plans to recommend that certain childhood vaccines be split up into separate shots. The policy proposal is apparently a follow-up to an Executive Order the President signed on Aug. 10 that calls for recommending the number of diseases for which children should be vaccinated be […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
Influenza-COVID Combo Vaccine Trial Halted Over Safety Concerns
The U.S. Food and Drug Administration (FDA) has put a hold on Novavax’s COVID-influenza combination vaccine and standalone influenza vaccines being tested in clinical trials after a participant reported nerve damage following receipt of the experimental vaccine in January 2024.1 Reported symptoms were diagnosed as motor neuropathy, a disease process that can be acquired, hereditary […]
Are Influenza Vaccine Failures One Reason for Declining Flu Shot Uptake?
The rates of adults and children in the United States receiving influenza vaccinations have been steadily declining in recent years, according to the U.S. Centers for Disease Control and Prevention (CDC). During the 2019-2020 “flu season,” 63.7 percent of American children between six months to 17 years of age received flu shots, compared to 55.4 […]
Vaccines, Doses & Shots. Confused?
In a phone conversation with Robert F. Kennedy, Jr. regarding childhood vaccinations last month, Donald Trump said: When you feed a baby, Bobby, a vaccination that is, like, 38 different vaccines and it looks like it’s been for a horse. Not a, you know, 10-pound or 20-pound baby. And then you see the baby all […]
WHO Prequalifies Takeda’s Qdenga Dengue Vaccine
On May 10, 2024, the World Health Organization (WHO) granted prequalification status to the Qdenga (TAK-003) dengue vaccine, developed by Takeda Pharmaceutical Company Ltd. of Tokyo, Japan. The live attenuated virus vaccine is recommended to be given in two doses three months apart to children six to 16 years old living in areas where dengue […]